Keyphrases
Tumor
81%
Ki-67
53%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
37%
Monoclonal Antibody
36%
Lymphocytes
32%
Immunohistochemical Study
30%
Apoptosis
29%
Head-and-neck
28%
MET Oncogene
28%
Radiotherapy
27%
Non-Hodgkin Lymphoma
27%
Lymph Node
25%
Immunohistochemistry
25%
Autophagy
24%
Mucosa
24%
Hodgkin Disease
24%
Levosimendan
24%
Chemotherapy
23%
Metastasis
23%
Tumor Cells
22%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
21%
B Cells
21%
Prognostic Factors
20%
MIB1
19%
Spleen
19%
Carcinoma
19%
Lymphoma
19%
Oral Cavity
18%
Nonalcoholic Steatohepatitis
18%
Cathepsin D
18%
Epstein-Barr Virus
18%
Oral Lichen Planus
18%
Ethmoid
18%
Lymph Node Metastasis
17%
Glioma
17%
T Cells
17%
In Situ Hybridization
17%
Malignancy
17%
Clinical Outcomes
17%
Salivary Gland
17%
Proliferative Activity
16%
Hepatocytes
16%
Squamous Cell Carcinoma (SqCC)
15%
Ischemia-reperfusion Injury
15%
Hematopoietic Cells
14%
Neoplastic Cells
14%
Lymphoid Tissue
14%
Disease-free Survival
14%
Beclin-1
14%
High-risk Human Papillomavirus (HR-HPV)
14%
Medicine and Dentistry
Neoplasm
100%
Metastatic Carcinoma
45%
Disease
41%
Carcinoma
36%
Head and Neck Squamous Cell Carcinoma
34%
Lymphocyte
31%
Radiation Therapy
30%
Autophagy
26%
Lymph Node
26%
Recurrent Disease
25%
Oncogene
24%
Oral Cavity
24%
Malignant Neoplasm
24%
Chemotherapy
24%
Programmed Cell Death
24%
Prognostic Factor
23%
Adenocarcinoma
23%
Immunohistochemistry
23%
Cancer
22%
Diagnosis
21%
Macrophage
20%
Biopsy Technique
20%
Squamous Cell Carcinoma
19%
Reperfusion Injury
18%
Neck
18%
Non-Hodgkin Lymphoma
18%
Lichen Planus
18%
Basal-Cell Carcinoma
18%
Blood Clotting Factor 8
18%
Levosimendan
18%
Lymph Node Metastasis
18%
B Cell
18%
Protein P53
17%
Hepatocyte
17%
Wart Virus
16%
Receptor
16%
Morphology
16%
Tumor Cell
16%
Monoclonal Antibody
16%
T Lymphocyte
15%
Scatter Factor Receptor
15%
Microvessel
15%
T Cell
15%
Gene Mutation
14%
Tumor Progression
14%
Overall Survival
14%
Clinical Feature
14%
Parotid Gland
14%
Dysplasia
13%
Necrosis
13%